ProfSamuel McConkey

Professor

International Health Tropical Medicine

  • Professor
    International Health Tropical Medicine
  • 01 4022204 (Work)
  • RCSI, International Health & Tropical Medicine, Beaux Lane House, Dublin, Dublin 2

RESEARCH OVERVIEW

Malaria Vaccines
International Health
Integrated development
Medical Education
Infectious Disease prevention.

GRANTS

  • FUNDED PROJECT
    A Phase 3b, multi-center, randomized, parallel group, open-label, non-inferiority study evaluating the efficacy, safety, and tolerability of oral dolutegravir/lamivudine once-daily as a first-line regimen compared to oral bictegravir/emtricitabine/tenofovir alafenamide once daily for Virologic suppression and maintenance in antiretroviral therapy naive adults living with HIV
    Industry – Company Sponsored Clinical Trial23 Sep 2024 - 22 Sep 2026
  • FUNDED PROJECT
    Stipend increase for non state-funded PhD scholars
    RCSI1 Jan 2024 - 30 Sep 2029
  • FUNDED PROJECT
    A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety and Tolerability of Switching to Long-Acting Cabotegravir plus Long-acting Rilpivirine administered every two months from a Bictegravir/emtricitabine/tenofovir alafenamide single tablet regimen in HIV-1 infected adults who are virologically suppressed
    Industry19 Feb 2021 - 2 Aug 2027
    People funded by this grant:
    • GlaxoSmithKline UKL
  • GRANT
    A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallelgroup, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine administered every two months from a Bictegravir/emtricitabine/tenofovir alfenamide Single Tablet Regimen in HIV-1 Infected Adults who are Virologically Suppressed.
    This study is sponsored by ViiV Healthcare. GlaxoSmithKline is supporting ViiV Healthcare in the conduct of this study.29 Nov 2020 - 26 Feb 2021
  • GRANT
    A Prospective Study of Cardiovascular Risk in Patients with HIV Attending a Regional Outpatients Department in Ireland
    Health Research Board (Ireland)24 Jun 2019 - 19 Aug 2019
    People funded by this grant:
    • McConkey S,
    • Cleary A
  • FUNDED PROJECT
    Multi-country, non-interventional, cohort study of the effectiveness, safety, adherence, and health-related quality of life in HIV-1 infected adult patients
    Gilead14 May 2019 - 23 Feb 2023
  • FUNDED PROJECT
    RCSI Research Summer School 2019
    RCSI12 Apr 2019 - 31 Jan 2022
  • FUNDED PROJECT
    Deputy Dean for International Curriculum Development
    RCSI12 Feb 2019 - 31 Mar 2027
  • GRANT
    Multi-country, non-interventional, cohort study of the effectiveness, safety, adherence, and health-related quality of life in HIV-1 infected adult patients receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
    Gilead Sciences Europe Ltd. (GSEL)28 Jan 2018 - 27 Jan 2022
    People funded by this grant:
    • Jackson A,
    • Lambert J,
    • Fleming C
  • FUNDED PROJECT
    HCV within Ireland’s migrant population: patient experiences and challenges in HCV healthcare
    Private Donor3 Oct 2016 - 2 Oct 2017
  • FUNDED PROJECT
    Establishment and maintenance of a Hepatitis C treatment database for the Department of Infectious Disease in Beaumont Hospital for patients seeking care in the RCSI hospitals region
    Industry30 May 2016 - 31 Dec 2016
    People funded by this grant:
    • Admin A
  • FUNDED PROJECT
    Understanding Health Information Systems and Decision-Making for Health: Case study based on new malaria surveillance system in The Gambia.
    RCSI11 Jan 2016 - 11 Jul 2016
  • GRANT
    Understanding Hep C treatment for migrants
    ICORN1 Jan 2016
  • FUNDED PROJECT
    A multi-centre, prospective, placebo-controlled, randomised trial of short course alendronate therapy to prevent loss of bone mineral density in antiretroviral-naïve, HIV-1 infected subjects initiatin
    Health Research Board / HRB1 Jan 2015 - 31 Dec 2018
    People funded by this grant:
    • Paddy M
  • GRANT
    APART clinical trial, HRB, Dublin – Randomised controlled trial of use of alendronate to prevent osteoporosis in people living with HIV
    Health Research Board (Ireland)1 Jan 2015
  • GRANT
    Hep C scale up
    Gilead and AbbVie1 Jan 2015
  • FUNDED PROJECT
    DARUNAVIR
    Industry5 Dec 2011 - 23 Nov 2015
  • FUNDED PROJECT
    A Circumsporozoite protein vaccine against malaria using the adenovirus Ch63 vector: preclinical and phase 1 safety & immunogenicity studies.
    European Vaccine Initiative1 Sep 2011 - 31 Oct 2013
    People funded by this grant:
    • Alfredo N,
    • Adrian H
  • FUNDED PROJECT
    ePredictis- Enterprise Ireland funding for salary for locum to facilitate Prof Mcconkey grant writing
    Enterprise Ireland26 Sep 2010 - 21 Dec 2012
  • GRANT
    Clinical Audit & Clinical Risk Management
    Merck, Sharp & Dohme1 Jan 2009
  • GRANT
    CS Vac. Vectored vaccines for malaria Phase I trials
    EMVI1 Jan 2009
  • FUNDED PROJECT
    Evaluate the use of systematic National Surveillance to inform decision-making in malaria prevention and control in The Gambia
    Health Research Board / HRB1 Jan 2008 - 31 Jul 2012
    People funded by this grant:
    • Ayo P,
    • Climent C-P,
    • Sana S,
    • Abdoulie C,
    • Malang F
  • FUNDED PROJECT
    Clinical Research Nurse for Dublin City HIV cohort and Prostate Cancer Consortium
    Private Donor10 Dec 2007 - 31 Aug 2013
  • GRANT
    Dublin City HIV Cohort- Proposal for Research Nurse at Beaumont Hospital
    Gilead1 Jan 2007
  • GRANT
    Development of high-throughput, cheap and reliable assays for monitoring HIV-1 and HIV-2 in ARV programmes and clinical trials in developing countries
    European and Developing Countries Clinical Trials Partnership1 Jan 2004